Buys
Open market- Shares
- Avg price
- Total value
Tai Sandi See - Chief Development Officer at Lexeo Therapeutics, Inc.
Issuer-level insider activity
- Role
- Chief Development Officer
- Issuer symbol
- LXEO on Nasdaq
- Entity type
- Individual
- SEC filing history
- Open SEC filing history
Identity
1 identity field
Source evidence
1 source field
Past-year transaction volume for Tai Sandi See in Lexeo Therapeutics, Inc.
Sells
Open market- Shares
- -4,656
- Avg price
- $8.62
- Total value
- -$40,128
Net
Past year- Shares
- -4,656
- Share %
- -100%
- Total value
- -$40,128
Reported holdings for Tai Sandi See in Lexeo Therapeutics, Inc.
Form 4 holding
Chief Development Officer
Lexeo Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 65,476
- Estimated value
- $606,962
- Report date
- 18 Nov 2025
- Price
- $9.27
- Ownership
- Direct
Form 4 holding
Chief Development Officer
Lexeo Therapeutics, Inc.
- Security class
- Stock Option (right to buy)
- Shares / value
- 77,500
- Estimated value
- Report date
- 07 Jan 2025
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Tai Sandi See in Lexeo Therapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.